Please try another search
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Name | Age | Since | Title |
---|---|---|---|
Ruedi Aebersold | - | - | Member of Scientific Advisory Board |
Lee H. Hartwell | - | - | Member of Scientific Advisory Board |
Melissa B. Epperly | 43 | 2021 | Independent Director |
Farzad Nazem | 59 | 2021 | Independent Director |
Joshua LaBaer | - | - | Member of Scientific Advisory Board |
Matthew McIlwain | 56 | 2021 | Independent Director |
Michael Seth Altman | 39 | 2021 | Independent Director |
Matthew L. Posard | 54 | 2021 | Independent Chairman of the Board |
Emma Lundberg | - | 2021 | Member of Scientific Advisory Board |
Vijay Satyanand Pande | 50 | 2021 | Independent Director |
Sujal M. Patel | 47 | 2021 | Co-Founder, CEO, President, Secretary & Director |
Parag Mallick | 44 | 2021 | Co-Founder, Chief Scientist & Director |
Karen Akinsanya | 54 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review